BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 20123967)

  • 1. Histone demethylase LSD1 regulates neural stem cell proliferation.
    Sun G; Alzayady K; Stewart R; Ye P; Yang S; Li W; Shi Y
    Mol Cell Biol; 2010 Apr; 30(8):1997-2005. PubMed ID: 20123967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orphan nuclear receptor TLX recruits histone deacetylases to repress transcription and regulate neural stem cell proliferation.
    Sun G; Yu RT; Evans RM; Shi Y
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15282-7. PubMed ID: 17873065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transrepressive function of TLX requires the histone demethylase LSD1.
    Yokoyama A; Takezawa S; Schüle R; Kitagawa H; Kato S
    Mol Cell Biol; 2008 Jun; 28(12):3995-4003. PubMed ID: 18391013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells.
    Sun G; Ye P; Murai K; Lang MF; Li S; Zhang H; Li W; Fu C; Yin J; Wang A; Ma X; Shi Y
    Nat Commun; 2011 Nov; 2():529. PubMed ID: 22068596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
    Vasilatos SN; Katz TA; Oesterreich S; Wan Y; Davidson NE; Huang Y
    Carcinogenesis; 2013 Jun; 34(6):1196-207. PubMed ID: 23354309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.
    El Mansouri FE; Nebbaki SS; Kapoor M; Afif H; Martel-Pelletier J; Pelletier JP; Benderdour M; Fahmi H
    Arthritis Res Ther; 2014 May; 16(3):R113. PubMed ID: 24886859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
    Metzger E; Wissmann M; Yin N; Müller JM; Schneider R; Peters AH; Günther T; Buettner R; Schüle R
    Nature; 2005 Sep; 437(7057):436-9. PubMed ID: 16079795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of Atrophin1 by lysine-specific demethylase 1 is required for cortical progenitor maintenance.
    Zhang F; Xu D; Yuan L; Sun Y; Xu Z
    Nat Commun; 2014 Dec; 5():5815. PubMed ID: 25519973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.
    Singh MM; Manton CA; Bhat KP; Tsai WW; Aldape K; Barton MC; Chandra J
    Neuro Oncol; 2011 Aug; 13(8):894-903. PubMed ID: 21653597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone lysine-specific demethylase 1 (LSD1) protein is involved in Sal-like protein 4 (SALL4)-mediated transcriptional repression in hematopoietic stem cells.
    Liu L; Souto J; Liao W; Jiang Y; Li Y; Nishinakamura R; Huang S; Rosengart T; Yang VW; Schuster M; Ma Y; Yang J
    J Biol Chem; 2013 Nov; 288(48):34719-28. PubMed ID: 24163373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine-specific demethylase 1 regulates the embryonic transcriptome and CoREST stability.
    Foster CT; Dovey OM; Lezina L; Luo JL; Gant TW; Barlev N; Bradley A; Cowley SM
    Mol Cell Biol; 2010 Oct; 30(20):4851-63. PubMed ID: 20713442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy.
    Schulte JH; Lim S; Schramm A; Friedrichs N; Koster J; Versteeg R; Ora I; Pajtler K; Klein-Hitpass L; Kuhfittig-Kulle S; Metzger E; Schüle R; Eggert A; Buettner R; Kirfel J
    Cancer Res; 2009 Mar; 69(5):2065-71. PubMed ID: 19223552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1.
    Schmidt DM; McCafferty DG
    Biochemistry; 2007 Apr; 46(14):4408-16. PubMed ID: 17367163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A.
    Mimasu S; Sengoku T; Fukuzawa S; Umehara T; Yokoyama S
    Biochem Biophys Res Commun; 2008 Feb; 366(1):15-22. PubMed ID: 18039463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.
    Kauffman EC; Robinson BD; Downes MJ; Powell LG; Lee MM; Scherr DS; Gudas LJ; Mongan NP
    Mol Carcinog; 2011 Dec; 50(12):931-44. PubMed ID: 21400613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of myelin transcription factor 1 (MyT1) as a subunit of the neural cell type-specific lysine-specific demethylase 1 (LSD1) complex.
    Yokoyama A; Igarashi K; Sato T; Takagi K; Otsuka I M; Shishido Y; Baba T; Ito R; Kanno J; Ohkawa Y; Morohashi K; Sugawara A
    J Biol Chem; 2014 Jun; 289(26):18152-62. PubMed ID: 24828497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.
    Lan F; Collins RE; De Cegli R; Alpatov R; Horton JR; Shi X; Gozani O; Cheng X; Shi Y
    Nature; 2007 Aug; 448(7154):718-22. PubMed ID: 17687328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis.
    Sun Q; Ding D; Liu X; Guo SW
    Reprod Biol Endocrinol; 2016 Apr; 14():17. PubMed ID: 27062244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency.
    Liang Y; Vogel JL; Narayanan A; Peng H; Kristie TM
    Nat Med; 2009 Nov; 15(11):1312-7. PubMed ID: 19855399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
    Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
    Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.